- Home
- FRST vs DCTH Comparison
FRST vs DCTH Comparison
Compare FRST & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRST | DCTH |
|---|---|---|
| Founded | 2004 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.2M | 350.7M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | FRST | DCTH |
|---|---|---|
| Price | $14.28 | $9.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 75.9K | ★ 481.6K |
| Earning Date | 01-29-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.49 | 0.03 |
| Revenue | ★ $211,298,000.00 | $79,603,000.00 |
| Revenue This Year | N/A | $132.21 |
| Revenue Next Year | $28.45 | $33.88 |
| P/E Ratio | ★ $5.68 | $288.94 |
| Revenue Growth | 117.38 | ★ 251.54 |
| 52 Week Low | $7.59 | $8.12 |
| 52 Week High | $14.38 | $18.23 |
Technical Indicators
Market Signals| Indicator | FRST | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 64.17 | 38.90 |
| Support Level | $13.07 | $9.74 |
| Resistance Level | $14.32 | $11.15 |
| Average True Range (ATR) | 0.43 | 0.43 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 83.50 | 11.28 |
Price Performance
Historical ComparisonAbout FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.